Associations of Restless Legs Syndrome with Various Neurological Disorders
An analysis of 119 unique studies found significant associations between restless legs syndrome (RLS) and several neurological conditions, including Parkinson's disease, multiple sclerosis, and amyotrophic lateral sclerosis, among others.
- Tags
- #MSResearch
- Most relevant to
- —
- Human efficacy
- Not established from this source
- Mechanism
- Not reported
- Evidence strength
- Not graded
- Outcome
- Not reported
Why it matters
These findings suggest that RLS may be linked to a variety of neurological disorders, which could influence further research into understanding these associations and their underlying mechanisms.
What this does not prove
The findings are based on observational studies, which can indicate associations but do not confirm causation. Additionally, the studies included are heterogeneous.
Next milestone
No next milestone was established from the available source.
Study facts
- Study design
- Not reported
- Participants / samples
- 119 · unique studies
- Randomised
- Not reported
- Controlled
- Not reported
- Primary endpoint met
- Not reported
- Relevant MS type
- Not reported
- Publication date
- 2026-10-17
- Evidence reviewed
- Abstract only
- Regulatory approval
- Not reported
- Research areas
- Not classified
- Biological target
- Not reported
- Pathway
- Not reported
- Population
- Not reported
- Size of effect
- Not reported
- Secondary endpoints
- Not reported
- MRI endpoints
- Not reported
- Biomarkers
- Not reported
- Safety
- Not reported
Original sources
- Primary evidenceRestless legs syndrome and other neurological disorders: A systematic-narrative hybrid literature review with exploratory meta-analysis. ↗DOI: 10.1016/j.smrv.2026.102390
Supporting passages (6)
sample size119
sample size basisunique studies
publication date2026-10-17
findingsIn our exploratory synthesis of 119 unique studies, RLS was significantly associated with Parkinson's disease (case-control OR 3.22, 95% CI 2.35-4.41; cohort RR 1.74, 95% CI 1.02-2.95), multiple sclerosis (OR 4.04, 95% CI 3.26-5.00), neuromyelitis optica spectrum disorder (OR 2.91, 95% CI 1.45-5.84), migraine or headache disorders (forward OR 2.72, 95% CI 2.19-3.38; reverse adjusted OR 1.53, 95% CI 1.36-1.73), peripheral neuropathy (OR 3.82, 95% CI 2.49-5.83), epilepsy (OR 2.11, 95% CI 1.58-2.82), and amyotrophic lateral sclerosis (OR 7.69, 95% CI 2.74-21.59).
limitationsHowever, the current evidence remains observational and heterogeneous.
peer reviewedPublication types: Journal Article; Review
AI assessment, not yet reviewed by a person · version 1 · Community votes are separate from evidence review.